期刊文献+

血红素氧化酶-1在表浅性膀胱癌中的表达及其意义 被引量:3

Expression of heme oxygenase-1 in human superficial bladder cancer
原文传递
导出
摘要 目的探讨血红素氧化酶-1(HO-1)在人表浅性膀胱癌中的表达及意义。方法应用免疫组织化学链霉菌抗生物素蛋白一过氧化物酶(SP)法检测46例初发表浅性膀胱癌,其中术后复发组21例,术后无复发组25例以及8例正常膀胱组织中HO-1的表达,比较3组之间及膀胱癌不同病理分级之间的差异。结果46例膀胱癌组织中38例(82.6%)呈阳性表达,而8例正常膀胱组织中仅1例阳性表达,差异有统计学意义(P〈0.05),其中21例复发组膀胱癌95.2%阳性表达,26例无复发组膀胱癌中72.0%阳性表达,HO-1表达在有无复发组间差异有统计学意义(P〈0.05)。HO-1的阳性细胞表达在不同病理分级间差异有统计学意义(P〈0.05)。结论HO-1蛋白的表达可能与表浅性膀胱癌的发生、发展和复发有关。 Objective To investigate the expression profile of heme oxygenase-1 in human superfi- cial bladder cancer. Methods The expression of heme oxygenase-1 ( HO-1 ) was detected by using immu- nohistochemical streptavid-in-peroxidase (SP) method in 46 cases of initial onset of superficial bladder cancer [ including postoperative recurrence group ( n -- 21 ) and postoperative no-recurrence group ( n -- 25 ) 1 , and 8 cases of normal bladder tissues. A comparison was made between recurrence group and no-re- currence group, and among the pathological grades. Results The positive rate of HO-1 protein in human bladder carcinoma was 82. 6% , significantly higher than that in the normal bladder tissues ( 12. 5%, P 〈 O. 05 ). There was significant difference in the expression of HO-1 between tissues of bladder carcinoma without recurrence and tissues of bladder carcinoma with recurrence ( P 〈 0. 05 ). There was significant difference in the expression of HO-1 among the pathological grades ( P 〈 0. 05 ). Conclusion The HO-1 expression may play an important role in the development, and recurrence of superficial bladder carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第12期2391-2392,I0002,I0003,共4页 Chinese Journal of Experimental Surgery
关键词 表浅性膀胱肿瘤 血红素氧化酶-1 免疫组织化学 Superficial bladder carcinoma Heme oxygenase-1 Immunohistochemistry
  • 相关文献

参考文献8

  • 1Maines MD. Heme oxygenase : function, multiplicity, regulatory mecha- nisms, and clinical applications. FASEB J, 1988,2:2557-2568.
  • 2Alicja J, Halina W, Jozef D. Heme oxygenase-1 in tumors : is it a false friend?. Antioxid Redox Signal ,2007,9:2099-2118.
  • 3张中明,陈德海,董红燕,张宜乾.血红素氧化酶-1对紫绀型兔心脏复氧及缺血再灌注损伤的保护作用[J].中华实验外科杂志,2005,22(4):510-510. 被引量:5
  • 4张正筠,陈曦,苏畅,顾卫琼,李宏为,周光文.血红素氧化酶-1对异种胰岛移植物的保护作用[J].中华实验外科杂志,2008,25(8):1084-1084. 被引量:3
  • 5Doi K,Akaike T, Fuji S, et al. Induction of heme oxygenase-1 nitric oxide and ischemia in experimental so|id tumors and implications for tumor growth. Br J Cancer, 1999,80 : 1945-1954.
  • 6Makito M, Kiyohide F, Satoshi A, et ak Clinical significance of heme oxygenase-1 expression in non-muscle-invasive bladder cancer. Urol Int, 20J O, 85 : 355-363.
  • 7孔垂泽,张铭铮.膀胱癌肿瘤血管生成的研究进展[J].中华实验外科杂志,2001,18(1):92-93. 被引量:5
  • 8Sunamura M, Duda DG, Ghattas MH,et al. Heine oxygenase-1 acceler- ate tumor angiogenesis of human pancreatic cancer. Angiogenesis, 2003,6 : 15-24.

二级参考文献9

共引文献9

同被引文献29

  • 1张中明,陈德海,董红燕,张宜乾.血红素氧化酶-1对紫绀型兔心脏复氧及缺血再灌注损伤的保护作用[J].中华实验外科杂志,2005,22(4):510-510. 被引量:5
  • 2Scott KL,Kabbarah 0,Uang MC,et al.G0LPH3 modulates mTORsignalling and rapamycin sensitivity in cancer.Nature,2009,459:1085-1090.
  • 3Kunigou O,Nagao H,Kawabata N,et al.Role of GOLPH3 and GOLPH3Lin the proliferation of human rhabdomyosarcoma.Oncol Rep,2011,26:1337-1342.
  • 4Hua X,Yu L,Pan W,et al.Increased expression of Golgi phospho-protein-3 is associated with tumor aggressiveness and poor prognosis ofprostate cancer.Diagn Pathol,2012,7:127.
  • 5Hu BS,Hu H,Zhu CY,et al.Overexpression of G0LPH3 is associatedwith poor clinical outcome in gastric cancer.Tumour Biol,2013,34:515-520.
  • 6Wang JH,Chen XT,Wen ZS,et al.High expression of GOLPH3 in e-sophageal squamous cell carcinoma correlates with poor prognosis.Plos One,2012,7;e45622.
  • 7Li H,Guo L,Chen SW,et at.GOLPH3 overexpression correlates withtumor progression and poor prognosis in patients with clinically NO o-ral tongue cancer.Transl Med,2012,10:168.
  • 8Zeng ZL,Lin HXtZhao XH,et al.Overexpression of G0LPH3 pro-motes proliferation and tumorigenicity in breast cancer via suppressionof the F0X01 transcription factor,Clin Cancer Res,2012,18:4059-4069.
  • 9Cook KM,Figg WD.Angiogenesis inhibitors:current strategies and fu-ture prospects.CA Cancer J Clin,2010,60:222-243.
  • 10Mori T,Sasaki J,Aoyama Y,et al.Modulation of endogenous VEGF-Aexpression under hypoxia by using artiiicial transcription factors.Nu-cleic Acids Symp Ser(Oxf),2008,52:187-188.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部